Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study - Archive ouverte HAL
Article Dans Une Revue Cancers Année : 2023

Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study

Résumé

(1) Background: Little data are available in Western countries regarding self-medication practices in the context of cancer. The aim of this study was to describe the prevalence of self-medication practices during (cancer patients) and after cancer (cancer survivors). (2) Methods: This multicenter, cross-sectional, and online study was designed to assess self-medication prevalence. Other objectives were explored, notably the medication types, the perceived risks, and the relation with symptoms and quality of life. (3) Results: Among the 518 patients analyzed, 56.4% declared they practiced self-medication. Dietary supplements and pain medications were used by more than half of the patients. Self-medication was practiced in order to manage the adverse effects of anticancer therapies (63.8%), for which pain was the leading indication (39%), and to improve the efficacy of anticancer therapies (43.8%, cancer patients). Patients believed that self-medication could not lead to drug interactions with anticancer therapies (84.9%, cancer patients), or to adverse effects (84.6%, cancer patients and survivors). Self-medication practices were associated with altered social functioning, pain, insomnia, and financial difficulties. (4) Conclusions: Self-medication was performed by more than half of the responders (ongoing or past cancer) and could be a marker of the undermanagement of cancer and treatment-related adverse effects.

Domaines

Cancer
Fichier principal
Vignette du fichier
Self-Medication during and after Cancer.pdf (1.07 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04213499 , version 1 (21-09-2023)

Licence

Identifiants

Citer

Julie Maraud, Sabrina Bedhomme, Bruno Pereira, Sophie Trévis, Marine Jary, et al.. Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study. Cancers, 2023, 15 (12), pp.3190. ⟨10.3390/cancers15123190⟩. ⟨hal-04213499⟩
64 Consultations
64 Téléchargements

Altmetric

Partager

More